Raw Writing for the Real World of Bipolar

I was glad to find this info on the combination of Geodon and Lithium since that's my med cocktail. Read on to find out more information:

Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom control in patients with bipolar disorder.

Bipolar disorder, which affects approximately 5.7 million adults in the United States, is a debilitating, chronic condition that requires lifelong treatment and management.1 More than 90 percent of patients with bipolar disorder have recurring mood episodes,2 making it important to establish a long-term treatment plan to help prevent recurrence and stabilize mood. The recurrence of mood episodes associated with bipolar disorder can have a devastating impact on patients’ lives, and the disease is associated with high rates of disability.3

"The FDA approval of Geodon provides an additional treatment option for patients with bipolar disorder, who require maintenance therapy to keep the symptoms of the disease under control," said Charles Bowden, clinical professor of psychiatry and pharmacology, University of Texas Health Science Center.

The efficacy and safety of Geodon for the adjunctive maintenance treatment of bipolar disorder were studied in a six-month, double-blind, randomized, placebo-controlled trial in adult patients with bipolar I disorder. After an open-label stabilization period of 10 to 16 weeks, 240 patients were randomized to continue on Geodon plus lithium or valproate, or to have Geodon replaced by placebo.4 The primary endpoint in this study was time to recurrence of a mood episode requiring intervention.

The data demonstrated that Geodon plus lithium or valproate was superior to placebo plus lithium or valproate in increasing the time to recurrence of a mood episode. During six months of treatment, 19.7 percent of patients in the Geodon arm required intervention for a mood episode, compared with 32.4 percent of patients in the placebo arm.4

The adjunctive Geodon treatment regimen was generally well-tolerated.4 Discontinuation due to adverse events occurred in 13 percent of patients in the placebo group, compared with 9 percent of those in the Geodon group.5 The safety and tolerability data from this study are consistent with Geodon’s already well-established safety profile in adult patients.

"The recurrence of mood episodes associated with bipolar disorder can have a devastating impact on patients’ lives,” said Dr. Ilise Lombardo, senior medical director, Pfizer Specialty Care. "This approval underscores Pfizer’s commitment to supporting people suffering from serious mental health disorders.”

Geodon is also FDA-approved for the treatment of acute manic and mixed episodes associated with bipolar disorder, with or without psychotic features, and for the treatment of schizophrenia. Since the FDA approval of Geodon in February 2001, nearly 2 million adult patients have been treated with this important therapy.

About the Author: Cristina C. Fender, 34, is rapidly becoming an expert on Bipolar Disorder. She has been researching Bipolar Disorder and blogging about her own experiences for several years. At age 21 she was diagnosed with depression and saw psychiatrists for over ten years before she was correctly diagnosed with Bipolar Disorder I. Her vision for writing at Raw Writing for the Real World of Bipolar is to inform and educate the public about mental illness. Feel free to Email Cristina a comment or a question.Share Your Own Bipolar Story. Click here to Subscribe in a Reader.

© 2009 Cristina C. Fender

Bobby Brown lied to his doctor and told him that he was Bipolar so he could get Medical Marijuana. Do most people lie about this disorder to get it,too?

I find this to be ludicrous. I think that Bobby Brown is the exception not the rule. I don't think that most people would disclose that they had Bipolar just to get marijuana. Why would anyone want to be labeled with a brand that scars your skin?

Bipolar disorder is a serious disease. It is real and it is scary. It was scary of me to admit to my doctor that I saw and heard things out of the ordinary. It was scary to admit that I had mania and depression episodes. I believe that others wouldn't want to admit the same things just to get marijuana.

I wasn't even aware that California had ruled that Bipolars could even get a prescription for Medical Marijuana. There is a pill form called Marinol that's available in some states. Currently only Canada, the UK, and Spain have stronger cannabis based treatments. And it's only recommended for depression. It can send some patients into mania.

I hope Bobby Brown's ill conceived attempt to get Medical Marijuana failed. There are so many of us out there that truly need the help.

About the Author: Cristina C. Fender, 34, is rapidly becoming an expert on Bipolar Disorder. She has been researching Bipolar Disorder and blogging about her own experiences for several years. At age 21 she was diagnosed with depression and saw psychiatrists for over ten years before she was correctly diagnosed with Bipolar Disorder I. Her vision for writing at Raw Writing for the Real World of Bipolar is to inform and educate the public about mental illness. Feel free to Email Cristina a comment or a question.Share Your Own Bipolar Story. Click here to Subscribe in a Reader.

© 2009 Cristina C. Fender